You are here

FDA approves another in a new class of cholesterol drugs

Amgen's Repatha joins Sanofi's Praluent; but potency of medications raises a key question

New York

THE US Food and Drug Administration (FDA) has approved the second drug in a novel class of powerful cholesterol-lowering medications.

The new drug, Repatha, made by Amgen, is intended for people with extremely high cholesterol levels and those with heart disease who cannot...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes